Dr. Laura Suggs, Ph.D.
Chief Technology Officer
Dr. Suggs is an Associate Professor of Biomedical Engineering at the University of Texas at Austin and is an expert in stem cell engineering and biomaterials, with extensive knowledge and experience with cell culture and growth factors.
The Suggs Lab aims to develop clinically relevant and robust strategies for enhancing the growth of cardiac and vascular tissue in vivo to restore function after injuries such as myocardial infarction, ischemia, and deep burns. Toward this goal we study the in vitro response of stem cells to pro-angiogenic gel materials we have developed, explore new strategies to encourage stem cell differentiation to cardiomyocytes, and assess the vessel forming ability of stem cells implanted within gel scaffolds in mouse injury models. We are also interested in creating novel self-assembling gel matrix materials for promoting angiogenesis that are injectable, biocompatible, and readily degradable into natural components that are easily metabolized by the body.
Investor and Member, Board of Advisers
Since the age of 12, Mark has been a natural businessman. Selling garbage bags door to door, the seed was planted early on for what would eventually become long-term success. After graduating from Indiana University - where he briefly owned the most popular bar in town - Mark moved to Dallas. After a dispute with an employer who wanted him to clean instead of closing an important sale, Mark created MicroSolutions, a computer consulting service. He went on to later sell MicroSolutions in 1990 to CompuServe.
In 1995, Mark and long-time friend Todd Wagner came up with an internet based solution to not being able to listen to Hoosiers Basketball games out in Texas. That solution was Broadcast.com - streaming audio over the internet. In just four short years, Broadcast.com (then Audionet) would be sold to Yahoo for $5.6 billion dollars.
Since his acquisition of the Dallas Mavericks in 2000, he has overseen the Mavs competing in the NBA Finals for the first time in franchise history in 2006 - and becoming NBA World Champions in 2011. They are currently listed as one of Forbes' most valuable franchises in sports.
In addition to the Mavs, Mark is chairman and CEO of AXS tv, one of ABC's "Sharks" on the hit show Shark Tank, and an investor in an ever-growing portfolio of businesses. He lives in Dallas with wife Tiffany, daughters Alexis and Alyssa, and son Jake.
Dr. Bob Metcalfe, Ph.D.
Member, Board of Advisers
Dr. Metcalfe is Professor of Innovation in the Cockrell School of Engineering at The University of Texas at Austin. While an engineer-scientist, Bob helped pioneer the Internet. In 1973, at the Xerox Palo Alto Research Center, he invented Ethernet, the local-area networking standard on which he shares four patents.
While an entrepreneur-executive (1979-1990), Dr. Metcalfe founded 3Com Corporation, the billion-dollar networking company where at various times he was Chairman, CEO, division general manager, and vice president of engineering, sales, and marketing. 3Com became part of HP in 2010.
While a publisher-pundit (1990-2000), Dr. Metcalfe was CEO of IDG’s InfoWorld Publishing Company (1992-1995). For eight years, he opined about the Internet in an InfoWorld column read weekly by half a million information technologists.
Dr. Metcalfe’s books include Packet Communication, Beyond Calculation, and Internet Collapses.
Dr. Don Kleinsek, Ph.D.
Member, Board of Advisers
Dr. Kleinsek is a veteran of over 30 years in the field of gerontology, delineating the mechanism(s) of the human aging process and focusing on translational medicine – the development of aging research discoveries into clinical products that reach the commercial sector. Notably his fundamental breakthrough in cholesterol metabolism was an important advancement in medicine and into the $20 billion marketplace for the number one drug in sales today, the statins. Currently his patented cell therapy products are cures for a variety of age-related conditions and is being readied for commercialization. He is a pioneer in personalized medicine and cellular therapeutics. His expertise includes the field of cell culture and bioengineering.
Dr. Kleinsek is the CEO and co-founder of Cellagen, LLC. Seeking expedited and effective medical solutions for the marketplace, he was one of the very early entrepreneurs to enter into the dawn of the biotechnology era in the 1980s and founded GeriGene Medical Corporation. Prior to this approach, Dr. Kleinsek was a faculty member at Baylor College of Medicine and the University of Wisconsin as well as Director/President of the Bjorksten Research Foundation, a 40 plus year old non-profit organization.